| Name | Title | Contact Details |
|---|
Epitome Networks is a Henrico, VA-based company in the Computers and Electronics sector.
As part of the LexisNexis family, Reed Tech serves its clients in the public and private sectors with the expertise required in the technology-focused fields of IP Services, Life Sciences and Government Solutions. The corporate culture is driven by a commitment to excellence, innovation, and a strong dedication to its customers, employees and community. Reed Tech has been working in the patent arena since it was awarded its first USPTO contract in 1969. Reed Tech has electronically captured and prepared for publication well over half of all US patents ever granted by the Patent Office. The company`s portfolio of advanced IP solutions allows patent professionals to gain a strategic edge, bringing clarity and insight to every stage of the patent workflow. Since 2005, Reed Tech has supported Life Sciences companies in formatting and submitting their regulatory data to the FDA and other agencies outside the United States. Subject matter experts at Reed Tech assist manufacturers of drug and medical device products by offering Software-as-a-Service and fully outsourced service solutions for Electronic Drug Listing, Unique Device Identification, Lot Distribution Reports and other structured content submissions to regulatory agencies. Reed Tech is an ISO 9001:2000 certified company. We optimize the balance between automation and human expertise to ensure the highest degree of quality and efficiency.
ariel technology is a Miami, FL-based company in the Computers and Electronics sector.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.
Verge Technologies is a San Jose, CA-based company in the Computers and Electronics sector.